Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis - Trial NCT01739673
Access comprehensive clinical trial information for NCT01739673 through Pure Global AI's free database. This phase not specified trial is sponsored by Cxlusa and is currently Completed. The study focuses on Infectious Keratitis. Target enrollment is 13 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Cxlusa
Timeline & Enrollment
N/A
Aug 01, 2011
Jul 01, 2014
Primary Outcome
Resolution of Signs and Symptoms of Infectious Keratitis
Summary
This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application
 (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of
 infectious keratitis.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01739673
Non-Device Trial